🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/12/2017 | 53,65 | 53,79 | 53,20 | 53,66 | +0,41% | 1,10% | 23.664.574 |
| 14/12/2017 | 53,82 | 54,14 | 53,40 | 53,44 | -1,58% | 1,38% | 10.623.890 |
| 13/12/2017 | 54,33 | 54,74 | 54,06 | 54,30 | -0,28% | 1,26% | 13.982.940 |
| 12/12/2017 | 54,27 | 54,55 | 54,04 | 54,46 | +1,30% | 0,95% | 14.454.750 |
| 11/12/2017 | 53,76 | 54,05 | 53,02 | 53,76 | +1,39% | 1,92% | 10.239.170 |
| 08/12/2017 | 52,78 | 53,02 | 52,16 | 53,02 | +1,46% | 1,65% | 10.923.723 |
| 07/12/2017 | 52,34 | 53,28 | 52,18 | 52,26 | +0,77% | 2,11% | 17.250.604 |
| 06/12/2017 | 51,95 | 53,37 | 51,71 | 51,86 | -2,55% | 3,20% | 21.217.703 |
| 05/12/2017 | 53,58 | 53,92 | 53,17 | 53,22 | -0,80% | 1,41% | 12.405.386 |
| 04/12/2017 | 53,37 | 54,11 | 53,31 | 53,65 | +0,63% | 1,50% | 14.085.120 |
| 01/12/2017 | 52,86 | 53,42 | 52,69 | 53,31 | +1,09% | 1,37% | 12.672.835 |
| 30/11/2017 | 52,66 | 53,33 | 52,51 | 52,74 | -0,16% | 1,56% | 16.139.619 |
| 29/11/2017 | 52,52 | 53,10 | 52,41 | 52,82 | +0,78% | 1,31% | 10.980.525 |
| 28/11/2017 | 52,41 | 52,61 | 51,92 | 52,41 | +0,70% | 1,31% | 13.446.783 |
| 27/11/2017 | 51,92 | 52,10 | 51,72 | 52,05 | +0,37% | 0,74% | 10.584.905 |
| 24/11/2017 | 52,00 | 52,13 | 51,63 | 51,86 | -0,04% | 0,95% | 4.549.682 |
| 22/11/2017 | 51,75 | 52,07 | 51,69 | 51,88 | +0,18% | 0,74% | 7.730.258 |
| 21/11/2017 | 51,87 | 52,34 | 51,70 | 51,78 | +0,31% | 1,23% | 14.369.442 |
| 20/11/2017 | 51,56 | 51,90 | 51,17 | 51,62 | -1,99% | 1,41% | 18.003.278 |
| 17/11/2017 | 52,48 | 52,89 | 52,24 | 52,67 | +0,05% | 1,24% | 10.358.537 |
| 16/11/2017 | 52,35 | 52,83 | 52,24 | 52,64 | +0,68% | 1,13% | 12.572.122 |
| 15/11/2017 | 52,25 | 52,58 | 51,91 | 52,29 | -0,35% | 1,28% | 12.290.315 |
| 14/11/2017 | 52,45 | 52,65 | 52,24 | 52,47 | -0,20% | 0,78% | 13.315.678 |
| 13/11/2017 | 52,78 | 52,98 | 52,54 | 52,58 | -0,68% | 0,83% | 14.135.738 |
| 10/11/2017 | 53,71 | 53,71 | 52,62 | 52,94 | -1,30% | 2,03% | 17.547.607 |
| 09/11/2017 | 53,96 | 54,06 | 53,07 | 53,64 | -0,65% | 1,84% | 14.818.825 |
| 08/11/2017 | 52,96 | 54,12 | 52,92 | 53,99 | +1,78% | 2,27% | 15.859.279 |
| 07/11/2017 | 53,32 | 53,62 | 52,84 | 53,04 | -0,52% | 1,45% | 15.008.513 |
| 06/11/2017 | 53,47 | 53,61 | 53,05 | 53,32 | -0,32% | 1,04% | 9.136.988 |
| 03/11/2017 | 52,77 | 53,70 | 52,66 | 53,49 | +1,25% | 1,97% | 10.281.718 |